Catalent

CTLT NYSE
53.15
-2.09
-3.78%
After Hours: 55.80 +2.65 +4.99% 16:21 08/23 EDT
Open
54.94
Prev Close
55.24
High
55.56
Low
52.98
Volume
899.55K
Avg Vol (3M)
719.66K
52 Week High
58.38
52 Week Low
29.23
% Turnover
0.62%
Market Cap
7.74B
1D
5D
1M
3M
1Y
5Y

Company Profile

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.
MORE >

Recently

Name
Price
%Change